Anthony Compton

Achieved improved patient care through the implementation of innovative clinical pharmacy services in hospital settings. Established successful medical affairs teams that advanced real-world evidence research initiatives and enhanced medical communications.

• Member: American Society of Hospital Pharmacists
• Atlanta Academy of Institutional Pharmacists
• National Pharmaceutical Society
• Georgia Society of Hospital Pharmacists
• American Heart Association
• Georgia Association for Athletic Excellence
• American College of Clinical Pharmacy
• Phi Lambda Sigma Pharmacy Leadership Society

• Compton A. A Practical Cost Analysis of Bivalirudin. Pharmacotherapy 2002;22(6 Pt 2): 119S-127S.
• Compton A. Cost of Complications in Percutaneous Coronary Interventions: The Impact of Drug Therapy. Pharmacy Practice News 2003.
• Compton, A. Therapeutic Interchange. Encyclopedia of Clinical Pharmacy. 2002; ppg.860-863.
• Nykamp D, Compton A, Fitzpatrick L. Cardiovascular Disease and OTCs: Limitations and Precautions. Drug Topics 2006; November 20, 2006: 62-70.
• Nykamp D, Compton A. Preparing Case Reports for Publication: A Guide for Pharmacists. The Consultant Pharmacist 2006;21(3):231-236.
• Logue R, Nykamp D, Compton A. Bioimpedence Monitoring in a Heart Failure Patient. Submitted to US Pharmacist. October 2005.
• Carter L, Nykamp D, Compton A. Dietary Supplements Use in Cardiovascular Disease. US Pharmacist, February 2005;30(2):75-84.
• Nykamp D, Fackih M, Compton A. Possible Association of Acute Lateral Wall Infarction and Bitter Orange Supplement. Annals of Pharmacotherapy, 38(5):812-816, 2004.
• Nykamp D, Compton A, Poteet V. Anagelide Therapy for Treatment of Thrombocytosis in a Patient with Coexisting Cardiovascular Disease. US Pharmacist, 29(6);3-17, 2004.
• Bolton S, Nykamp D, Compton A. A Case of Amiodarone-Induced Hypothyroidism. US Pharmacist, 29(1):HS9-HS-14, 2004.

• Pharmacy Practice Residency: Extensive clinical and patient care experience which included Burn Trauma, heart transplant, heart lung transplant, kidney, and trauma rotations. The clinical pharmacist was considered a very valuable part of the medical team. Responsibilities include interdisciplinary patient rounds, medication management, adverse event monitoring and other patient outcome tasks. A requirement of this practice was designing and participating in medication management strategies. This residency required direct interaction with physicians, nurses, and other members of the patient care team. The residency also allowed rotations and direct patient care in other patient populations which included cardiology, interventional cardiology, nephrology, and intensive care.
• Critical Care Pharmacy: Primary pharmacist in a critical care pharmacy satellite for a 30-bed critical care unit. This position required me to perform all aspects of pharmacy patient care for this population of patients including medication order interpretation, computer entry, compounding and dispensing of critical care medications, distribution, staff and family education, and monitoring of patient outcomes and responses to medications. This also included participating in cardiac and pulmonary resuscitation teams. The patient populations supported during this practice included trauma, myocardial infarction, heart and renal failure, infectious disease, and pulmonary.
• Clinical Pharmacist: This position allowed a focus on direct clinical pharmacy practice. Responsible patient populations included cardiology, interventional cardiology, oncology, endocrine, nephrology, and critical care. In addition, a significant portion of the responsibilities focused on medication management for all patient populations. Patient care rounds were required for the position and allowed for the development of critical relationships with hospital administration, physicians, nurses, outcomes, and safety teams. An important function of this position was the development of a closed formulary system but most importantly, evaluating patient outcomes, medication errors, and adverse events. The position required cardiac and pulmonary resuscitation team involvement. The hospital had a very vibrant research practice and one of my roles included serving on the hospital’s IRB committee. Later in my tenure at the hospital, I served as Vice-Chair for the IRB committee. During this portion of my clinical career, a discharge patient medication discharge service was developed in addition to medication education services and grand round presentation to the medical, nursing, and support staffs. The clinical coordinator position that followed included all the patient care responsibilities described above with the addition of supervising an interdisciplinary clinical pharmacy team that included nurses, dietitians, and other clinical pharmacists.
• Interventional Cardiology Clinical Pharmacy: This was a very interesting practice population because it started during the introduction of the glycoprotein IIb/IIIa inhibitors for STEMI. When introduced, these medications were not well understood by the medical or nursing teams regarding medication selection, administration, monitoring, and patient outcome reporting for the cardiac catheterization and holding areas. The position required direct participation in the cardiac catheterization laboratory during interventional procedures and the development of medication education and patient monitoring plans. Because of the cost of these medications, effective patient outcome and evaluation tools were developed with physician support. This was very difficult because the hospital had over 50 interventional cardiologists; therefore, effective communication skills and support were required to obtain physician and administration by-in. Medication Usage Evaluations and Outcomes Analysis procedures were developed to evaluate effectiveness with patient outcomes. During my tenure as Pharmacy Director, I still had direct patient care responsibilities for this patient population.

• "Self-Learning Text in Critical Care Pharmacy." Management Case Presentation. The American Society of Hospital Pharmacists Mid-Year Clinical Meeting. Atlanta, Georgia 1987.
• "The Stability and Pharmacodynamics of an Extemporaneously Prepared Quinidine Sulfate Suspension." Resident Presentation. The Southeastern Preceptor-Resident Conference. Athens, Georgia 1986.
• "The Use of Tissue Plasminogen Activator in an Occluded Pedal Artery." Poster Presentation. The American Society of Hospital Pharmacists Mid-Year Clinical Meeting. San Francisco, California. June 1988.
• "Justifying, Implementing, and Maintaining Clinical Pharmacy Services During Cost Containment." Management Case Presentation. The American Society of Hospital Pharmacists Mid-Year Clinical Meeting. Atlanta, Georgia. December 1989.
• "Expanding Clinical Pharmacy Services." Georgia Society of Hospital Pharmacists End of Summer Meeting. Jekyll Island, Georgia. July 1991.
• "Current Management of Hypertension." Georgia Society of Hospital Pharmacists Fall Meeting. Athens, Georgia. October 1991.
• "The Effects of Computerization on the Provision of Patient Medication Information." Management Case Presentation. American Society of Hospital Pharmacists Mid-Year Clinical Meeting. New Orleans, Louisiana. December 1991.
• "Current Concepts for the Management of Congestive Heart Failure." Georgia Society of Hospital Pharmacy Fall Meeting. Athens, Georgia. October 1993.
• "Congestive Heart Failure." Athens Area Pharmaceutical Association. Athens, Georgia. April 1993.
• "General Pharmacology." Master of Science Physical Therapy Program. Emory University. Atlanta, Georgia. April 1991-present.
• "Dysrhythmia Therapy." Doctor of Pharmacy Program. Mercer University. Atlanta, Georgia. May 1994.
• "What's New in Cardiology." Atlanta Association of Institutional Pharmacy. Atlanta, Georgia. February 1995.
• "Developing an Effective Adverse Drug Reaction Monitoring and Reporting Program." Georgia Society of Hospital Pharmacists Fall Meeting. Athens, Georgia. October 1992.
• "Clinical Pharmacy Practice." National Pharmaceutical Association Regional Meeting. Atlanta, Georgia. April 1991.
• "Cardiovascular Health: The Wonder Years Through the Golden Years." American Heart Association Health-site Program. Moderator. Atlanta, Georgia. February 1993.
• "Overview of Antifungal Therapy.” Georgia Society of Hospital Pharmacy Regional Meeting. Atlanta, Georgia. October 1995.
• “Overview of Heart Failure.” American Association of Critical Care Nurses Regional Meeting. Birmingham, Alabama. October 1995.
• “Pharmacological Aspects of Hypertension Management.” Georgia Society of Healthcare Pharmacists Chattahoochee District Meeting. Columbus, Georgia. January 1997.
• “Pharmacological Management of Hypertension.” American Heart Association Minority Women’s Health Forum. World Congress Center. Atlanta, Georgia. February 1997.
• “Pharmacological management of Hypertension.” American Heart Association Minority Women’s Health Forum. World Congress Center. Atlanta, Georgia. February 1999.
• “Managing High-Cost Medications.” American College of Cardiovascular Administrators. New Orleans Louisiana., March 1999.